BioSpace News Archive

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2019.

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading company in leveraging computational biology to design novel products for life-science-based industries including: human health, agriculture and industrial applications, announces today that Eran Kosover, CEO of AgPlenus, Evogene’s subsidiary designing effective and sustainable crop protection products, will attend in the BofA 2020 Global Agriculture and Materials Conference

Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2019 results.

Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment (TME), announced today that it has entered into a collaboration agreement with Moffitt Cancer Center.

INCLINE VILLAGE, Nev. , Feb. 25, 2020 /PRNewswire/ -- PDL BioPharma, Inc. (“PDL” or the “Company”) (Nasdaq: PDLI) announces that Dominique Monnet , PDL’s president and chief executive officer, will present at the Cowen and Company 40 th Annual Health Care Conference on Tuesday, March 3, 2020 at 10:40 a.m. Eastern time ( 7:40 a.m. Pacific time ). The conference is being h

Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, announced that Mark Heffernan, Scout Bio’s Chief Executive Officer, will present a company overview and update at the 40th Annual Cowen Health Care Conference at 10:00 a.m. ET on Tuesday, March 3, 2020 in Boston, MA.

The world’s first FDA-cleared four-mode radiofrequency microneedling system allows practitioners to deliver a variety of customized treatments on single device

Partnership Combines Shared Drug Discovery Expertise with Integrated Artificial Intelligence to Identify Promising Targets in Half the Time of Traditional R&D Approaches

Company Presentation on Thursday, February 27, 2020 at 11:00 AM Eastern Time

ENGLEWOOD, Colo. , Feb. 25, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced the U.S. Food and Drug Administration (“FDA”) granted 510(k) clearance for sa